EICHOR
● Completed
Low-Dose Atropine for Treatment of Myopia
Condition: Myopia · Sponsor: Jaeb Center for Health Research
About this study
Study Objectives The objectives for this randomized trial are: 1. To determine the efficacy of daily low-dose atropine (0.01%) for slowing myopia progression over a two-year treatment period in children aged 5 to less than 13 years (Primary Outcome On-Treatment). 2. To determine the efficacy of atropine treatment on myopia progression 6 months following cessation of low-dose atropine treatment (Secondary Outcome Off-Treatment). Synopsis of Study Design The current study is designed as an efficacy study, making effort to maximize adherence to treatment group assignments. After a run-in phase during which all participants are treated with daily artificial tear eyedrops for 2-4 weeks (and glasses are updated if required) to assess their ability to adhere to daily eye drops, participants are randomly assigned to daily atropine or placebo for 24 months, followed by 6 months off treatment.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (13)
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| The Emory Eye Center Dept of Ophthalmology | Atlanta, Georgia, United States | — |
| St Luke's Hospital | Boise, Idaho, United States | — |
| Illinois College of Optometry | Chicago, Illinois, United States | — |
| Ticho Eye Associates | Chicago Ridge, Illinois, United States | — |
| Boston Children's Hospital Waltham | Boston, Massachusetts, United States | — |
| Pediatric Ophthalmology Associates, Inc. | Columbus, Ohio, United States | — |
| Eye Care Associates, Inc. | Poland, Ohio, United States | — |
| Dean A. McGee Eye Institute, University of Oklahoma | Oklahoma City, Oklahoma, United States | — |
| Casey Eye Institute | Portland, Oregon, United States | — |
| Vanderbilt University Medical Center - Vanderbilt Eye Institute | Nashville, Tennessee, United States | — |
| University of Houston College of Optometry | Houston, Texas, United States | — |
+ 1 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03334253